Cambridge University Researchers Develop and Administer Lab-developed Red Blood Cells in Clinical Study with Promising Results for the Blood Supply

Sickle cell patients and others who need long-term blood transfusions provided by clinical laboratories and others would benefit most from successfully lab-grown blood Administering lab-developed red blood cells in humans in a clinical study conducted in the United Kingdom (UK) is being hailed as a significant step forward in efforts to supplement the supply of whole blood through the development of synthetic blood products. Of interest to those clinical laboratory managers overseeing hospital...

New Innovation Gives Clinical Pathology Laboratories Opportunity to Use Dried Blood Spot Specimens in Medical Lab Testing

More sensitive analytical technologies allow medical laboratories to perform more sophisticated tests using tiny blood specimens on paper New breakthroughs are creating the opportunity to use “dried blood spot” (DBS) technology in an expanded number of pathology and clinical laboratory testing applications. The latest innovation was developed in the United Kingdom and allows more sophisticated applications of this decades-old screening method. This new technology was announced in a press...
;